Drug Discovery

Canada’s PharmaDrug signs agreement to acquire Securedose Synthetics

Canadian company PharmaDrug has signed a definitive agreement to acquire Securedose Synthetics, a privately-held pharmaceutical research and development company.

ThermoGenesis opens cell and gene therapy facility in Sacramento, US

ThermoGenesis Holdings has opened a new 35,500ft² ReadyStart-IncuStart cGMP facility in Greater Sacramento in Northern California, US.

Caris, Moderna partner for mRNA-based oncology therapeutics advancement

Caris Life Sciences and Moderna have signed a new multi-year agreement for advancing mRNA-based oncology therapeutics.

Nona and BeiGene agree to expand antibody discovery partnership

HBM Holdings wholly-owned subsidiary Nona Biosciences has signed an agreement for the expansion of its antibody discovery collaboration with BeiGene.

Synaffix, ABL Bio partner to develop bispecific ADCs

Lonza company Synaffix has signed a licensing agreement with ABL Bio for the development of bispecific antibody drug conjugates (ADCs).

Salipro and Sumitomo Pharma sign partnership for drug discovery programme

Salipro Biotech and Sumitomo Pharma have entered into a research partnership for advancing a drug discovery programme.

United Italian Trading launches GERD drug in Singapore

RaQualia Pharma’s sublicensee United Italian Trading (UITC) has launched the tegoprazan drug for the treatment of gastroesophageal reflux disease (GERD), in Singapore.

Innovac raises funding for lead programmes development

Innovac Therapeutics has raised $18m in Series Pre-A financing for funding the development of its lead programmes and manufacturing capabilities.

Allucent to expedite Covid-19 booster vaccines development

Allucent has received a contract from the Biomedical Advanced Research and Development Authority (BARDA) to expedite clinical research and development of next-generation booster vaccines for Covid-19.